Notably, despite the low expression of ESR1 (Figure S21), the estrogen response pathway still showed significant enrichment in tumor regions (Figure S24), emphasizing the power of pathway-based analyses to refine breast cancer classification. Here, ESR1 is linked to breast carcinoma.